Endothelin-1 stimulates proliferation of human coronary smooth muscle cells via the ET(A) receptor and is co-mitogenic with growth factors

Atherosclerosis

Volumn 146, Issue 2, 1999, Pages 351-359

  Hafizi, Sassan ^a   Allen, Sean P ^a   Goodwin, Andrew T ^a   Chester, Adrian H ^a   Yacoub, Magdi H ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Cell; Coronary; Endothelins; Growth factors; Receptors; Smooth muscle

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CYCLIN D1; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN 1; EPIDERMAL GROWTH FACTOR; GROWTH FACTOR; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE; PLATELET DERIVED GROWTH FACTOR; RECEPTOR SUBTYPE; SARAFOTOXIN S6C;

ARTICLE; CALCIUM CELL LEVEL; CELL COUNT; CELL CYCLE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; CORONARY ARTERY; DNA SYNTHESIS; HUMAN; HUMAN CELL; MITOGENESIS; PRIORITY JOURNAL; PROTEIN SYNTHESIS; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

BLOTTING, WESTERN; CALCIUM; CELL COUNT; CORONARY VESSELS; DNA; ENDOTHELIN-1; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; GROWTH SUBSTANCES; HEART DISEASES; HUMANS; INTRACELLULAR FLUID; MICROSCOPY, FLUORESCENCE; MITOSIS; MUSCLE DEVELOPMENT; MUSCLE, SMOOTH, VASCULAR; PEPTIDES, CYCLIC; PLATELET-DERIVED GROWTH FACTOR; PROTEIN BIOSYNTHESIS; PROTEINS; RECEPTOR, ENDOTHELIN A; RECEPTORS, ENDOTHELIN; RECOMBINANT PROTEINS; THYMIDINE;

EID: 0032840751     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(99)00178-1     Document Type: Article

References (34)

1. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990's. Nature. 362:1993;801-809.
2. Newby A.C., George S.J. Proposed roles for growth factors in mediating smooth muscle proliferation in vascular pathologies. Cardiovasc Res. 27:1993;1173-1183.
3. Webb D.J. Endothelin: from molecule to man. Br J Clin Pharmacol. 44:1997;9-20.
4. Haug C., Voisard R., Lenich A., Baur R., Höher M., Osterhues H., Hannekum A., Vogel U., Mattfeldt T., Hombach V., Grunert A. Increased endothelin release by cultured human smooth muscle cells from atherosclerotic coronary arteries. Cardiovasc Res. 31:1996;807-813.
5. Douglas S.A., Louden C., Vickery Clark L.M., Storer B.L., Hart T., Feuerstein G.Z., Elliott J.D., Ohlstein E.H. A role for endogenous endothelin-1 in neointimal formation after rat carotid artery balloon angioplasty. Protective effects of the novel nonpeptide endothelin receptor antagonist SB 209670. Circ Res. 75:1994;190-197.
6. Hirata Y., Takagi Y., Fukuda Y., Marumo F. Endothelin is a potent mitogen for rat vascular smooth muscle cells. Atherosclerosis. 78:1989;225-228.
7. A receptor antagonist BQ123 antagonizes endothelin-1-mediated mitogenesis. Eur J Pharmacol. 225:1992;347-350.
8. Peiro C., Redondo J., Rodriguez Martinez M.A., Angulo J., Marin J., Sanchez Ferrer C.F. Influence of endothelium on cultured vascular smooth muscle cell proliferation. Hypertension. 25:1995;748-751.
9. Weissberg P.L., Witchell C., Davenport A.P., Hesketh T.R., Metcalfe J.C. The endothelin peptides ET-1, ET-2, ET-3 and sarafotoxin S6b are co-mitogenic with platelet-derived growth factor for vascular smooth muscle cells. Atherosclerosis. 85:1990;257-262.
10. Fujitani Y., Bertrand C. ET-1 cooperates with EGF to induce mitogenesis via a PTX- sensitive pathway in airway smooth muscle cells. Am J Physiol. 272:1997;C1492-C1498.
11. Fujitani Y., Ninomiya H., Okada T., Urade Y., Masaki T. Suppression of endothelin-1-induced mitogenic responses of human aortic smooth muscle cells by interleukin-1β J Clin Invest. 95:1995;2474-2482.
12. Assender J.W., Irenius E., Fredholm B.B. Endothelin-1 causes a prolonged protein kinase C activation and acts as a co-mitogen in vascular smooth muscle cells. Acta Physiol Scand. 157:1996;451-460.
13. Bacon C.R., Cary N.R.B., Davenport A.P. Endothelin peptide and receptors in human atherosclerotic coronary artery and aorta. Circ Res. 79:1996;794-801.
14. Pollock D.M., Keith T.L., Highsmith R.F. Endothelin receptors and calcium signaling. FASEB J. 9:1995;1196-1204.
15. 1 receptor blockade. Coron Artery Dis. 9:1998;167-175.
16. Weber H., Taylor D.S., Molloy C.J. Angiotensin II induces delayed mitogenesis and cellular proliferation in rat aortic smooth muscle cells. Correlation with the expression of specific endogenous growth factors and reversal by suramin. J Clin Invest. 93:1994;788-798.
17. 2+ indicators with greatly improved fluorescence properties. J Biol Chem. 260:1985;3440-3450.
18. Haynes W.G., Webb D.J. Contribution of endogenous generation of endothelin-1 to basal vascular tone. Lancet. 344:1994;852-854.
19. Quelle D.E., Ashmun R.A., Shurtleff S.A., Kato J.Y., Bar Sagi D., Roussel M.F., Sherr C.J. Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts. Genes Dev. 7:1993;1559-1571.
20. Hafizi S., Nobin R., Allen S.P., Chester A.H., Yacoub M.H. Contrasting effects of platelet-derived growth factor (PDGF) isomers on mitogenesis, contraction and intracellular calcium concentration in human vascular smooth muscle. Acta Physiol Scand. 164:1998;191-199.
21. Koide M., Kawahara Y., Tsuda T., Ishida Y., Shii K., Yokoyama M. Endothelin-1 stimulates tyrosine phosphorylation and the activities of two mitogen-activated protein kinases in cultured vascular smooth muscle cells. J Hypertens. 10:1992;1173-1182.
22. B. Am J Physiol. 267:1994;C1130-C1135.
23. Okada K., Nishida Y., Murakami H., Sugimoto I., Kosaka H., Morita H., Yamashita C., Okada M. Role of endogenous endothelin in the development of graft arteriosclerosis in rat cardiac allografts. Antiproliferative effects of bosentan, a nonselective endothelin receptor antagonist. Circulation. 97:1998;2346-2351.
24. A receptor antagonism reduces neointimal hyperplasia in a porcine coronary stent model. Circulation. 97:1998;2551-2556.
25. Goodwin A.T., Amrani M., Gray C.C., Jayakumar J., Yacoub M.H. Role of endogenous endothelin in the regulation of basal coronary tone in the rat. J Physiol. 511:1998;549-557.
26. A receptor-mediated constrictor responses to endothelin peptides in human blood vessels in vitro. Br J Pharmacol. 115:1995;191-197.
27. Pate M.A., Chester A.H., Brown T.J., Roach A.G., Yacoub M.H. Atypical antagonism observed with BQ123 in human saphenous vein. J Cardiovasc Pharmacol. 31:1998;S172-S174.
28. 2+ signalling by endothelin receptors in rat and human cultured airway smooth muscle cells. Br J Pharmacol. 125:1998;1768-1778.
29. Dagassan P.H., Breu V., Clozel M., Kunzli A., Vogt P., Turina M., Kiowski W., Clozel J.P. Up-regulation of endothelin-B receptors in atherosclerotic human coronary arteries. J Cardiovasc Pharmacol. 27:1996;147-153.
30. A sub-type. Br J Pharmacol. 114:1995;1110-1116.
31. Dashwood M.R., Timm M., Muddle J.R., Ong A.C.M., Tippins J.R., Parker R., McManus D., Murday A.J., Madden B.P., Kaski J.C. Regional variations in endothelin-1 and its receptor subtypes in human coronary vasculature: Pathophysiological implications in coronary disease. Endothelium. 6:1998;61-70.
32. Colucci W.S. Myocardial endothelin. Does it play a role in myocardial failure? Circulation (editorial). 93:1996;1069-1072.
33. Holm P., Franco-Cereceda A. Haemodynamic influence and endothelin-1 plasma concentrations by selective or non-selective endothelin receptor antagonists in the pig in vivo. Acta Physiol Scand. 165:1999;163-168.
34. Hafizi S., Chester A.H., Yacoub M.H. Molecular mechanisms of vascular smooth muscle cell growth. Curr Opin Cardiol. 12:1997;495-503.